Table 2.
General demographic data of study participants
| Variables | Values |
|---|---|
| Age (years) (mean ± SD) | 51.79 ± 13.54 (29–81) |
| Menarche age (years) (mean ± SD) | 13 ± 1.65 (10–18) |
| Menopause age (years) (mean ± SD) | 44.91 ± 14.91 (38–60) |
| First pregnancy age (years) (mean ± SD) | 18.04 ± 8.36 (14–32) |
| Breast feeding duration (months) (mean ± SD) | 41.62 ± 34.1 (3–120) |
| Positive family history for cancer (%) | 17% |
| Cancer stage (%) | |
| I | 30.8 |
| II | 28.8 |
| III | 30.8 |
| IV | 9.6 |
| Overall grade (%) | |
| I | 17 |
| II | 49 |
| III | 34 |
| Mitotic rate (%) | |
| I | 45.2 |
| II | 42.9 |
| III | 11.9 |
| Tumor size (%) | |
| < 2 cm | 32 |
| ≥ 2 cm, < 5 cm | 66 |
| ≥ 5 cm | 2 |
| Estrogen receptor (%) | |
| Positive | 87.8 |
| Negative | 12.2 |
| Progesterone receptor (%) | |
| Positive | 77.1 |
| Negative | 22.9 |
| Her2/neu expression (%) | |
| Positive | 25 |
| Negative | 75 |
| Ki67 expression (%) | |
| Positive | 100 |
| Negative | 0 |